VISHAY INTERTECHNOLOGY INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data VISHAY INTERTECHNOLOGY INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,323	2,603	3,035	2,668	2,502	3,240	3,497	3,402	2,938	3,069
Cost of revenue	1,754	1,904					2,438	2,428	2,311	2,474
Gross profit	574	703	889	671	582	888	1,059	974	626	595
Research and development	66.8	67.2	72.9	69.8	70.9	77.4	81.2	99.5	120	122
Selling, general and administrative	356	368	403	385	371	420	444	488	514	538
Operating income	197	324	485	262	210	468	615	486	5.63	56.9
Interest expense	25.6	27.9	36.7	33.7	31.6	17.5	17.1	25.1	27.5	38.7
Other non-operating income	-103	-44.6	-68.3	-36.1	-51.4	-33.2	-22	-18.7	-8.02	-31.4
Pre-tax income	94.2	279	417	226	158	435	594	467	-2.39	25.5
Income tax	44.8	299	70.2	61.5	34.5	136	163	142	27.4	34.5
Net income to minority interests	0.58	0.78	0.78	0.85	0.86	0.97	1.67	1.69	1.4	0
Net income	48.8	-20.3	346	164	123	298	429	324	-31.2	-8.98
EBITDA	356	487	647	427	376	635	779	671	216	282
EPS, basic	0.33	-0.14	2.39	1.13	0.85	2.05	2.99	2.32	-0.23	-0.07
EPS, diluted	0.32	-0.14	2.24	1.13	0.85	2.05	2.98	2.31	-0.23	-0.07
Shares, basic (weighted)	147	146	144	145	145	145	143	139	137	136
Shares, diluted (weighted)	151	146	155	145	145	145	144	140	137	136
Dividend per share	0.25	0.26	0.32	0.37	0.38	0.39	0.40	0.40	0.40	0.40

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	472	748	686	694	620	774	611	973	590	515
Receivables	274	340	397	328	339	396	416	427	402	382
Inventory	381	430	480	432	448	537	619	648	689	759
Other current assets	111	130	143	141	132	157	170	214	218	231
Total current assets	1,864	2,195	1,784	1,704	1,697	2,010	2,121	2,297	1,916	1,887
Property, plant and equipment	849	906	969	952	943	979	1,130	1,295	1,546	1,673
Lease right-of-use assets			0	93.2	102	118	131	127	118	120
Goodwill	141	143	147	151	158	165	201	201	179	180
Intangible assets	84.5	69.8	65.7	60.7	66.8	67.7	77.9	72.3	87.2	78.5
Other non-current assets	139	149	140	161	98	108	98.8	110	106	112
Total assets	3,081	3,462	3,106	3,121	3,154	3,543	3,866	4,240	4,111	4,234
Accounts payable	174	222	218	174	196	254	189	191	216	215
Accrued liabilities	115	136	142	122	141	163	166	162	137	164
Deferred revenue		36.7	42.7	40.5	39.6	39.8	47	47.8	43.4	41.2
Short-term debt	0	0	0	0	0	0	0	0	0	0
Total current liabilities	457	563	644	520	562	694	726	692	708	720
Long-term debt	357	370	495	499	395	456	501	818	905	951
Lease liabilities			0	78.5	86.2	100	108	103	94.2	95.8
Other non-current liabilities	59.7	75.2	79.5	100	104	95.9	92.5	87.9	104	109
Total liabilities	1,418	1,778	1,720	1,633	1,575	1,797	1,816	2,039	2,082	2,146
Total debt	357	370	495	499	395	456	501	818	905	951
Paid-in capital	1,953	1,753	1,436	1,425	1,409	1,348	1,352	1,291	1,306	1,101
Retained earnings	-307	-362	-61.3	72.2	139	402	773	1,041	956	892
Treasury stock						0	-83	-162	-212	0
Other comprehensive income	-94.7	25.7	-6.79	-26.6	13.6	-20.3	-10.8	10.3	-35.3	81.4
Shareholders' equity	1,566	1,430	1,382	1,485	1,576	1,744	2,046	2,196	2,029	2,088
Minority interests	5.44	2.03	2.29	2.54	2.8	2.97	3.9	4.73	0
Total equity	1,573	1,432	1,385	1,488	1,579	1,747	2,050	2,201	2,029	2,088
Total liabilities and equity	3,078	3,462	3,106	3,121	3,154	3,543	3,866	4,240	4,111	4,234

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	49.4	-19.6	347	165	124	299	430	326	-29.8	-8.98
Depreciation and amortization	159	163	162	164	166	167	164	184	211	225
Stock-based compensation	6.38	4.39	4.82	6.11	5.28	6.61	6.55	16.5	20.9	22.4
Deferred income tax	-2.52	52.4	-212	-61.8	-28.4	50.6	13.5	-26.8	-38.5	-20.2
Change in receivables	-4.12	-51.2	-62.4	66.2	4.66	-67.7	-26.7	-3.72	17.5	39.3
Change in inventory	13.8	-55.1	-80.2	18.8	-24.2	-121	-120	-58.8	-78.5	-74.9
Cash from operations	297	369	259	296	315	457	484	366	174	184
Capital expenditures	-135	-170	-230	-157	-124	-218	-325	-329	-320	-273
Acquisitions	0	0	-14.9	-11.9	-25.9	-20.8	-50	-13.8	-216	0
Purchases of investments	-555	-750	-175	-112	-293	-141	-286	-118	-145	-28.6
Cash from investing	-149	-34.8	269	-195	-192	-230	-529	-72.9	-512	-258
Debt issued	0	0	600	0	0	0	0	750	0	0
Stock issued	0.36	1.26	0	0
Share buybacks	-23.2	-39.9	0	0	0	0	-83	-78.7	-50.4	-12.5
Cash from financing	-143	-77.2	-576	-90	-209	-58.8	-101	61.1	-35.4	-19.7
Exchange rate effect					12.3	-13.6	-17.6	7.98	-8.27	18
Net change in cash		276	-62	8.1	-74.3	154	-163	362	-382	-75.3
Free cash flow	162	198	28.6	140	191	239	159	36.3	-146	-89
Interest paid	19.3	21.2	23.9	16.2	15.5	14.2	13.7	17.2	21.7	33.8
Income taxes paid	58.8	76.9	249	186	69.7	79.1	134	224	137	101

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $32.55 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.9%	Gross profit / revenue.
Operating margin	3.3%	Operating income / revenue.
EBITDA margin	10.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.2%	Pre-tax income / revenue.
Net margin	0.9%	Net income / revenue.
FCF margin	-0.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.4%	Cash from operations / revenue.
Effective tax rate	60.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	1.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.6%	Net income / average total assets.
Return on invested capital (ROIC)	3.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	10.6%	Capital expenditures / revenue.
D&A / revenue	6.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-17.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	0.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	910.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-54.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-23.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	30.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-28.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-5.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	6.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-27.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-10.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	1.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	2.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.80x	Current assets / current liabilities.
Quick ratio	1.12x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.86x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.33x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.9%	Total debt / total assets.
Liabilities / assets	43.5%	Total liabilities / total assets.
Net debt	-$325.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.98x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.77x	Operating income / interest expense.
Working capital	$1.21B	Current assets - current liabilities.
Goodwill and intangibles / assets	4.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.66B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.64x	Revenue / average total assets.
Fixed asset turnover	1.90x	Revenue / average property, plant and equipment.
Inventory turnover	3.25x	Cost of revenue / average inventory.
Days inventory	112 days	365 x average inventory / cost of revenue.
Receivables turnover	8.44x	Revenue / average receivables.
Days sales outstanding	43 days	365 x average receivables / revenue.
Days payables	33 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	122 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-24.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	102.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.19	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$22.44	Revenue / diluted weighted shares.
FCF per share	-$0.05	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.34	Cash from operations / diluted weighted shares.
Book value per share	$19.69	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18.00	Tangible book value / shares outstanding.
Cash per share	$8.77	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$4.99B	Share price x shares outstanding.
Enterprise value	$4.67B	Market cap + total debt - cash - short-term investments.
P/E	176x	Market cap / net income. Only when net income is positive.
P/S	1.50x	Market cap / revenue.
P/B	1.71x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.88x	Market cap / tangible book value, when positive.
P/OCF	14.4x	Market cap / cash from operations, when positive.
EV/Sales	1.41x	Enterprise value / revenue.
EV/EBIT	42.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.0x	Enterprise value / EBITDA, when both are positive.
FCF yield	-0.1%	Free cash flow / market cap.
Earnings yield	0.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was VISHAY INTERTECHNOLOGY INC's revenue in fiscal 2025?

VISHAY INTERTECHNOLOGY INC reported revenue of $3.07B for fiscal 2025, 4.5% higher than the year before.

Was VISHAY INTERTECHNOLOGY INC profitable in fiscal 2025?

No. It reported a net loss of $9.0M.

How much free cash flow did VISHAY INTERTECHNOLOGY INC generate in fiscal 2025?

Cash from operations of $184.3M minus capital expenditures of $273.3M left free cash flow of -$89.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to VISHAY INTERTECHNOLOGY INC